HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy.

AbstractBACKGROUND:
Immune features of infants with food allergy have not been delineated.
OBJECTIVES:
We sought to explore the basic mechanisms responsible for food allergy and identify biomarkers, such as skin prick test (SPT) responses, food-specific IgE levels, and mononuclear cell responses, in a cohort of infants with likely milk/egg allergy at increased risk of peanut allergy.
METHODS:
Infants aged 3 to 15 months were enrolled with a positive SPT response to milk or egg and either a corresponding convincing clinical history of allergy to milk or egg or moderate-to-severe atopic dermatitis. Infants with known peanut allergy were excluded.
RESULTS:
Overall, 512 infants (67% male) were studied, with 308 (60%) having a history of a clinical reaction. Skin test responses, detectable food-specific IgE, or both revealed sensitization as follows: milk, 78%; egg, 89%; and peanut, 69%. SPT responses and food-specific IgE levels were discrepant for peanut (15% for IgE > or = 0.35 kU(A)/L and negative SPT response vs 8% for positive SPT response and IgE <0.35 kU(A)/L, P = .001). Mononuclear cell allergen stimulation screening for CD25, cytokine-inducible SH2-containing protein (CISH), forkhead box protein 3 (FOXP3), GATA3, IL10, IL4, IFNG, and T-box transcription factor (TBET) expression by using casein, egg white, and peanut revealed that only allergen-induced IL4 expression was significantly increased in those with clinical allergy to milk (compared with nonallergic subjects) and in those sensitized to peanut, despite the absence of an increase in GATA3 mRNA expression.
CONCLUSIONS:
Infants with likely milk/egg allergy are at considerably high risk of having increased peanut-specific IgE levels (potential allergy). Peanut-specific serum IgE levels were a more sensitive indicator of sensitization than SPT responses. Allergen-specific IL4 expression might be a marker of allergic risk. Absence of an increase in GATA3 mRNA expression suggests that allergen-specific IL-4 might not be of T-cell origin.
AuthorsScott H Sicherer, Robert A Wood, Donald Stablein, A Wesley Burks, Andrew H Liu, Stacie M Jones, David M Fleischer, Donald Y M Leung, Alexander Grishin, Lloyd Mayer, Wayne Shreffler, Robert Lindblad, Hugh A Sampson
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 125 Issue 5 Pg. 1077-1083.e8 (May 2010) ISSN: 1097-6825 [Electronic] United States
PMID20451041 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Allergens
  • Interleukin-4
  • Immunoglobulin E
Topics
  • Allergens (immunology)
  • Arachis (immunology)
  • Dermatitis, Atopic (immunology)
  • Egg Hypersensitivity (complications, immunology)
  • Female
  • Humans
  • Immunoglobulin E (blood)
  • Infant
  • Interleukin-4 (immunology, metabolism)
  • Leukocytes, Mononuclear (immunology)
  • Male
  • Milk Hypersensitivity (complications, immunology)
  • Peanut Hypersensitivity (diagnosis, immunology)
  • Risk Factors
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: